The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.
In this episode, ECDC's Director Andrea Ammon, gives us the lowdown on the agency's new extended mandate and the EU regulation on serious cross-border threats to health.
From 13-17 March, ECDC organised the MediPIET Chemical, Biological, Radiological and Nuclear (CBRN) Awareness and Mitigation Module in Petrovac, Montenegro.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.
For 2020, nine EU/EEA countries reported 22 cases of Zika virus (ZIKV) disease, the lowest number
ever reported since the start of EU/EEA surveillance in 2016. All cases with available information (20/22) were associated with travel outside the EU/EEA. All cases with available information (7/22) were infected through mosquitoes.